20.52
Schlusskurs vom Vortag:
$20.99
Offen:
$20.89
24-Stunden-Volumen:
2.32M
Relative Volume:
0.29
Marktkapitalisierung:
$14.27B
Einnahmen:
$125.68M
Nettoeinkommen (Verlust:
$4.81B
KGV:
3.631
EPS:
5.65
Netto-Cashflow:
$-781.21M
1W Leistung:
+2.11%
1M Leistung:
-0.46%
6M Leistung:
+85.24%
1J Leistung:
+67.96%
Roivant Sciences Ltd Stock (ROIV) Company Profile
Firmenname
Roivant Sciences Ltd
Sektor
Branche
Telefon
441-295-5950
Adresse
7TH FLOOR, 50 BROADWAY, LONDON
Vergleichen Sie ROIV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd
|
20.52 | 14.60B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-02 | Eingeleitet | Citigroup | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-01-05 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Eingeleitet | Guggenheim | Buy |
| 2023-06-08 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-27 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Eingeleitet | Goldman | Buy |
| 2021-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-28 | Eingeleitet | Citigroup | Buy |
| 2021-10-26 | Eingeleitet | Cowen | Outperform |
| 2021-10-26 | Eingeleitet | Jefferies | Buy |
| 2021-10-26 | Eingeleitet | Truist | Buy |
Alle ansehen
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
iSAM Funds UK Ltd Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences stock hits all-time high at $21.36 By Investing.com - Investing.com Canada
Roivant Sciences stock hits all-time high at $21.36 - Investing.com
Roivant Sciences Ltd. $ROIV is SB Investment Advisers UK Ltd.'s 3rd Largest Position - MarketBeat
88,495 Shares in Roivant Sciences Ltd. $ROIV Acquired by Franklin Resources Inc. - MarketBeat
Cash per share of Roivant Sciences Ltd. – MUN:87S - TradingView
Roivant Sciences (NASDAQ:ROIV) Reaches New 52-Week HighWhat's Next? - MarketBeat
Affinity Asset Advisors LLC Purchases 250,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Earnings Beat: Why Roivant Sciences Ltd stock could rally in 2025Quarterly Portfolio Report & High Return Trade Guides - BỘ NỘI VỤ
Roivant Sciences Ltd. $ROIV Position Increased by Two Seas Capital LP - MarketBeat
Roivant Sciences Ltd. $ROIV Shares Sold by Pertento Partners LLP - MarketBeat
Is Roivant Sciences Ltd. stock safe for conservative investors2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Why Roivant Sciences Ltd. stock could rally in 2025Dividend Hike & Weekly Breakout Watchlists - Newser
How Roivant Sciences Ltd. (87S) stock compares with market leadersJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Roivant Sciences Ltd. (87S) stock undervalued by metricsWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Will Roivant Sciences Ltd. stock recover faster than peers2025 Market Overview & Capital Efficiency Focused Strategies - Newser
How Roivant Sciences Ltd. (87S) stock trades after rate cutsM&A Rumor & High Win Rate Trade Tips - Newser
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
Why analysts recommend Roivant Sciences Ltd. (87S) stockJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
Is Roivant Sciences Ltd. (87S) stock prepared for digital transitionWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Why Roivant Sciences Ltd. (87S) stock signals breakout potential2025 Dividend Review & Risk Managed Investment Strategies - Newser
Rhumbline Advisers Reduces Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
Swiss National Bank Lowers Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Loomis Sayles & Co. L P Sells 352,443 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
(ROIV) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
33,356 Shares in Roivant Sciences Ltd. $ROIV Acquired by Inceptionr LLC - MarketBeat
Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN
Volume Report: Why Roivant Sciences Ltd. stock could be next big winnerEarnings Miss & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Roivant Sciences Ltd. $ROIV is Tejara Capital Ltd's 10th Largest Position - MarketBeat
Bank Watch: Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Reactions & Low Drawdown Momentum Ideas - moha.gov.vn
Te Ahumairangi Investment Management Ltd Increases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
SG Americas Securities LLC Has $489,000 Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Growth Report: Why Roivant Sciences Ltd. stock is in analyst buy zoneWeekly Risk Summary & Weekly Return Optimization Alerts - BỘ NỘI VỤ
Can Roivant Sciences Ltd. stock double in next 5 years2025 Technical Overview & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
Top Growth Companies With Strong Insider Ownership For November 2025 - Yahoo Finance UK
Why Roivant Sciences Ltd. stock could be next big winnerWeekly Loss Report & Weekly High Return Opportunities - BỘ NỘI VỤ
Roivant Sciences (NASDAQ:ROIV) Shares Acquired Rep. Lisa C. McClain - MarketBeat
QVT Financial LP Reduces Stake in Roivant Sciences Ltd - GuruFocus
Entropy Technologies LP Cuts Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
[Form 4] Roivant Sciences Ltd. Insider Trading Activity - Stock Titan
Pres Venker Surrenders 7,051 Of Roivant Sciences Ltd [ROIV] - TradingView
Indian-origin billionaire Vivek Ramaswamy’s 80% net worth surge is NOT all from US politics - financialexpress.com
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling By Investing.com - Investing.com Nigeria
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling - Investing.com Nigeria
Roivant Sciences Insider Sold Shares Worth $26,304,500, According to a Recent SEC Filing - marketscreener.com
Neo Ivy Capital Management Takes Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (87S.SG) Q4 FY2025 earnings call transcript - Yahoo Finance
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):